- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Type 2 diabetes mellitus (T2DM)
- Meeting Date: March 2021
- Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 1282KB)
- Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 88KB)
Semaglutide – March 2021
Semaglutide: Solution for injection 2 mg in 1.5 mL pre-filled pen, Solution for injection 4 mg in 3 mL pre-filled pen; Ozempic®
Last updated
2 July 2021